Patents Assigned to MEDOLUTION LIMITED
  • Substituted heterocyclic compounds as kinases inhibitors and methods of use thereof
    Patent number: 8748453
    Abstract: The present invention is directed to novel quinolines and quniazolines, their derivatives, pharmaceutically acceptable salts, solvates and hydrates thereof which are useful for the treatment of protein kinases mediated diseases and conditions. The compounds of this invention have a general Formula (I) wherein R1 to R11 and X are defined herein.
    Type: Grant
    Filed: June 24, 2010
    Date of Patent: June 10, 2014
    Assignee: Medolution Limited
    Inventor: Dawei Zhang
  • SUBSTITUTED HETEROCYCLIC COMPOUNDS AS KINASES INHIBITORS AND METHODS OF USE THEREOF
    Publication number: 20120101116
    Abstract: The present invention is directed to novel quinolines and quniazolines, their derivatives, pharmaceutically acceptable salts, solvates and hydrates thereof which are useful for the treatment of protein kinases mediated diseases and conditions. The compounds of this invention have a general Formula (I) wherein R1 to R11 and X are defined herein.
    Type: Application
    Filed: June 24, 2010
    Publication date: April 26, 2012
    Applicant: MEDOLUTION LIMITED
    Inventor: Dawei Zhang
  • Urea Derivatives as Kinase Inhibitors
    Publication number: 20120077851
    Abstract: The present invention is directed to novel ureas, their derivatives, pharmaceutically acceptable salts, solvates and hydrates thereof which are useful for the treatment of protein kinases mediated diseases and conditions. The compounds of this invention have a general Formula (I) wherein R, R1 to R10 are defined herein.
    Type: Application
    Filed: June 8, 2010
    Publication date: March 29, 2012
    Applicant: MEDOLUTION LIMITED
    Inventor: Dawei Zhang